476 related articles for article (PubMed ID: 33257644)
21. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results.
Duggan NM; Ludy SM; Shannon BC; Reisner AT; Wilcox SR
Am J Emerg Med; 2021 Jan; 39():256.e1-256.e3. PubMed ID: 32703607
[TBL] [Abstract][Full Text] [Related]
22. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.
Babiker A; Marvil CE; Waggoner JJ; Collins MH; Piantadosi A
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33361342
[TBL] [Abstract][Full Text] [Related]
23. Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections.
Egri N; Calderón H; Martinez R; Vazquez M; Gómez-Caverzaschi V; Pascal M; Araújo O; Juan M; González-Navarro EA; Hernández-Rodríguez J
Front Immunol; 2023; 14():1146841. PubMed ID: 37180097
[TBL] [Abstract][Full Text] [Related]
24. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
[TBL] [Abstract][Full Text] [Related]
25. Genomic evidence for reinfection with SARS-CoV-2: a case study.
Tillett RL; Sevinsky JR; Hartley PD; Kerwin H; Crawford N; Gorzalski A; Laverdure C; Verma SC; Rossetto CC; Jackson D; Farrell MJ; Van Hooser S; Pandori M
Lancet Infect Dis; 2021 Jan; 21(1):52-58. PubMed ID: 33058797
[TBL] [Abstract][Full Text] [Related]
26. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
[TBL] [Abstract][Full Text] [Related]
27. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
28. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
[TBL] [Abstract][Full Text] [Related]
30. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
[TBL] [Abstract][Full Text] [Related]
31. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.
Awada H; Nassereldine H; Hajj Ali A
J Med Case Rep; 2021 Jul; 15(1):382. PubMed ID: 34271967
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit JD; Gómez-Olivé FX; Dawood FS; Mkhencele T; Sun K; Viboud C; Tempia S;
Lancet Infect Dis; 2022 Jun; 22(6):821-834. PubMed ID: 35298900
[TBL] [Abstract][Full Text] [Related]
33. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.
Wilkins JT; Hirschhorn LR; Gray EL; Wallia A; Carnethon M; Zembower TR; Ho J; DeYoung BJ; Zhu A; Rasmussen-Torvik LJ; Taiwo B; Evans CT
Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1207-1215. PubMed ID: 34369331
[TBL] [Abstract][Full Text] [Related]
34. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
35. Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.
Maier HE; Kuan G; Saborio S; Carrillo FAB; Plazaola M; Barilla C; Sanchez N; Lopez R; Smith M; Kubale J; Ojeda S; Zuniga-Moya JC; Carlson B; Lopez B; Gajewski AM; Chowdhury M; Harris E; Balmaseda A; Gordon A
Clin Infect Dis; 2022 Aug; 75(1):e257-e266. PubMed ID: 34411230
[TBL] [Abstract][Full Text] [Related]
36. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies.
Bean DJ; Monroe J; Turcinovic J; Moreau Y; Connor JH; Sagar M
Clin Infect Dis; 2022 Aug; 75(1):e208-e215. PubMed ID: 34755830
[TBL] [Abstract][Full Text] [Related]
37. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test.
Brogna C; Brogna B; Bisaccia DR; Giuliano M; Montano L; Cristoni S; Petrillo M; Piscopo M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630059
[TBL] [Abstract][Full Text] [Related]
39. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
[TBL] [Abstract][Full Text] [Related]
40. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
